Clinical Trial Update: Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating peginterferon alfa-2b as maintenance therapy in multiple myeloma patients who responded to induction therapy; the study is completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2011-12-02